Skip to navigation | Skip to main content | Skip to footer

Commercialisation

Commercialisation of our intellectual property (IP) offers your business the opportunity to reap the benefits of innovations emanating from our world-class research.

We have a rich history of innovation and pioneering new technologies, and offer a range of technology transfer and IP investment opportunities across diverse market sectors.

How enterprise investment is managed at the University

The University of Manchester I3 Ltd (UMI3) is the University’s innovation company. UMI3 has two operational divisions: its Innovation Centre (UMIC) with state-of-the-art incubator premises and a vibrant enterprise conferencing and networking centre, and its intellectual property commercialisation service (UMIP).

The mission of UMI3 is to bring the University’s ground-breaking inventions and software into the commercial world. This is done principally by attracting entrepreneurs, investors and corporate venture partners to our campus and innovation centre, and then licensing or spinning out companies through engagement with our academic colleagues.

Commercialisation case studies

The following are two examples of spin-out companies that have brought innovations to market:

  • Acoustek, whose leak-detection technology was licensed to Pipeline Engineering
  • Bioxydyn, a developer of diagnostic imaging tools that is now working with the pharmaceutical industry.

Download our commercialisation case studies leaflet (PDF document, 707KB) to read more.

You can download other case studies, which include examples of enterprise investment and the transfer of IP through licensing and spin-outs, from the UMIP website.

Contact UMIC for laboratory/office space and conferencing/events:

Email: info@umic.co.uk

Contact UMIP for intellectual property commercialisation:

Email: info@umip.com